Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2024 -3.238M
March 31, 2024 -2.472M
December 31, 2023 -3.266M
September 30, 2023 -3.726M
June 30, 2023 -3.681M
March 31, 2023 -3.782M
December 31, 2022 -3.303M
September 30, 2022 -3.489M
June 30, 2022 -3.443M
March 31, 2022 -3.331M
December 31, 2021 -2.98M
September 30, 2021 -2.398M
June 30, 2021 -3.092M
March 31, 2021 -2.561M
December 31, 2020 -2.642M
September 30, 2020 -2.168M
June 30, 2020 -1.796M
March 31, 2020 -3.60M
December 31, 2019 -6.843M
September 30, 2019 -1.982M
June 30, 2019 -1.871M
March 31, 2019 -2.26M
December 31, 2018 -1.862M
September 30, 2018 -2.638M
June 30, 2018 -2.393M
Date Value
March 31, 2018 -2.292M
December 31, 2017 -2.552M
September 30, 2017 -2.025M
June 30, 2017 -2.727M
March 31, 2017 -2.092M
December 31, 2016 -1.572M
September 30, 2016 -1.57M
June 30, 2016 -2.507M
March 31, 2016 -3.54M
December 31, 2015 -3.117M
September 30, 2015 -3.105M
June 30, 2015 -6.073M
March 31, 2015 -5.843M
December 31, 2014 -5.807M
September 30, 2014 -6.708M
June 30, 2014 -7.237M
March 31, 2014 -8.154M
December 31, 2013 -8.627M
September 30, 2013 -7.251M
June 30, 2013 -7.866M
March 31, 2013 -6.763M
December 31, 2012 -9.517M
September 30, 2012 -7.745M
June 30, 2012 -7.948M
March 31, 2012 28.84M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.567M
Amgen, Inc. 2.375B
Anika Therapeutics, Inc. 3.309M
BioCryst Pharmaceuticals, Inc. 78.40M
Imunon, Inc. -2.814M